ES8802017A1 - Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina - Google Patents

Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Info

Publication number
ES8802017A1
ES8802017A1 ES557747A ES557747A ES8802017A1 ES 8802017 A1 ES8802017 A1 ES 8802017A1 ES 557747 A ES557747 A ES 557747A ES 557747 A ES557747 A ES 557747A ES 8802017 A1 ES8802017 A1 ES 8802017A1
Authority
ES
Spain
Prior art keywords
image
lower alkyl
prostaglandin analogs
congener
oxabicycloheptane substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557747A
Other languages
English (en)
Other versions
ES557747A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES8802017A1 publication Critical patent/ES8802017A1/es
Publication of ES557747A0 publication Critical patent/ES557747A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

DERIVADOS DE DIAMIDAS SUSTITUIDAS CON 7-OXABICICLOHEPTANO Y SUS ANALOGOS DE PROSTAGLANDINA (I), DONDE M ES 0 A 4, N, 1 A 5, P ES 1 A 4, Q ES 1 A 12, X ES 1 A 5 Y NO EXCLUSIVAMENTE, A ES -CHFCHY R1, R2 Y R3 SON H O ALQUILO INFERIOR; SE OBTIENEN POR REACCION DE WITTIG DE UN COMPUESTO (I), CON OTRO (III). FARMACOLOGICAMENTE UTILES COMO AGENTES CARDIOVASCULARES Y EN PARTICULAR PARA EL TRATAMIENTO DE LA ENFERMEDAD TROMBOTICA.
ES557747A 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina Expired ES8802017A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75094885A 1985-07-01 1985-07-01
US06/853,788 US4663336A (en) 1985-07-01 1986-04-18 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Publications (2)

Publication Number Publication Date
ES8802017A1 true ES8802017A1 (es) 1988-03-16
ES557747A0 ES557747A0 (es) 1988-03-16

Family

ID=27115346

Family Applications (10)

Application Number Title Priority Date Filing Date
ES556530A Expired ES8801626A1 (es) 1985-07-01 1986-06-24 Procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina.
ES557753A Expired ES8802020A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557752A Expired ES8802019A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557748A Expired ES8801898A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557747A Expired ES8802017A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557746A Expired ES8802016A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557750A Expired ES8801899A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557749A Expired ES8900229A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557751A Expired ES8802018A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557754A Expired ES8800896A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES556530A Expired ES8801626A1 (es) 1985-07-01 1986-06-24 Procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina.
ES557753A Expired ES8802020A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557752A Expired ES8802019A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557748A Expired ES8801898A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Family Applications After (5)

Application Number Title Priority Date Filing Date
ES557746A Expired ES8802016A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557750A Expired ES8801899A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557749A Expired ES8900229A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557751A Expired ES8802018A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ES557754A Expired ES8800896A1 (es) 1985-07-01 1987-09-23 Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina

Country Status (20)

Country Link
US (1) US4663336A (es)
EP (1) EP0207684B1 (es)
JP (1) JPH07103125B2 (es)
KR (1) KR910004721B1 (es)
CN (1) CN1009645B (es)
AT (1) ATE114312T1 (es)
AU (1) AU603058B2 (es)
CA (1) CA1284643C (es)
DE (1) DE3650144T2 (es)
DK (1) DK162528C (es)
ES (10) ES8801626A1 (es)
FI (1) FI93218C (es)
GR (1) GR861711B (es)
HU (1) HU196779B (es)
IE (1) IE65827B1 (es)
IL (1) IL79210A (es)
NO (1) NO168038C (es)
NZ (1) NZ216544A (es)
PH (1) PH22413A (es)
PT (1) PT82875B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1278577C (en) * 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
US4958036A (en) * 1986-06-04 1990-09-18 E. R. Squibb & Sons, Inc. Enantiomerically selective synthesis of certain N-substituted-2-(carbamyl 7-oxabicyclo[2.2.1]heptane-3-carboxylic acids
US4743697A (en) * 1986-06-04 1988-05-10 E. R. Squibb & Sons, Inc. Process for preparing 7-oxabicycloheptane amino-alcohol intermediates useful in making thromboxane A2 receptor antagonists and novel intermediates procuced therein
US4749715A (en) * 1987-03-02 1988-06-07 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amino prostaglandin analogs
US4931460A (en) * 1987-09-17 1990-06-05 E. R. Squibb & Sons, Inc. Post-ischemic myocardial dysfunction using thromboxane A2 antagonists
US5066480A (en) * 1988-04-11 1991-11-19 E. R. Squibb & Sons, Inc. Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist
USH1139H (en) 1988-07-21 1993-02-02 E. R. Squibb & Sons, Inc. Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US4839384A (en) * 1988-10-07 1989-06-13 E. R. Squibb & Sons, Inc. Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
US4965279A (en) * 1988-11-18 1990-10-23 E. R. Squibb & Sons, Inc. Cyclopropyl aza prostaglandin analogs
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5153327A (en) * 1988-12-23 1992-10-06 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
CA2006086A1 (en) * 1989-01-17 1990-07-17 A. K. Gunnar Aberg Method of preventing or treating atherosclerosis using a thromboxane a receptor antagonist
CA2007896A1 (en) * 1989-02-06 1990-08-06 A.K. Gunnar Aberg Method of treating hypertension using a thromboxane a2 receptor antagonist and new combinations
CA2012852A1 (en) * 1989-05-01 1990-11-01 Miguel A. Ondetti Method of inhibiting vasospasm and platelet aggregation resulting from angioplasty using thromboxane a receptor antagonists
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US4975279A (en) * 1989-10-10 1990-12-04 E. R. Squibb & Sons, Inc. Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination
US5141865A (en) * 1989-11-17 1992-08-25 E. R. Squibb & Sons, Inc. Monoclonal antibodies which bind thromboxane A2 receptor antagonists and diagnostic methods based thereon
US5081266A (en) * 1990-02-26 1992-01-14 E. R. Squibb & Sons, Inc. Process for preparing [1S-[1α,2α(Z),3α,4α]]-7-[3-[[[[(1-oxoheptyl)-amino]acetyl]amino]methyl]-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid
US4978762A (en) * 1990-02-26 1990-12-18 E. R. Squibb & Sons, Inc. Process for preparing [1S-[1α,2α)Z),3α,4α]]-7-[3-[[[[[1-oxoheptyl]-amino]acetyl]amino]methyl]-7-oxabicyclo-[2,2,1]hept-2-yl]-5-heptenoic acid
JP2984077B2 (ja) * 1990-04-19 1999-11-29 塩野義製薬株式会社 スルホニルアミノ置換ビシクロ環系ヒドロキサム酸誘導体
EP0468681B1 (en) * 1990-07-27 1995-05-24 Zeneca Limited Alfa-fluorocarboxylic acid derivatives as intermediates for the preparation of fungicides
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5245055A (en) * 1990-12-18 1993-09-14 E. R. Squibb & Sons, Inc. Process for preparing a cis oxabicyclo olefinic acid and ester from an oxabicyclo pyranol
US5084387A (en) * 1990-12-18 1992-01-28 E. R. Squibb & Sons, Inc. Microbiological hydrolysis for the preparation of (exo,exo)-7-oxabicyclo(2.2.1) heptane-2,3, monoacyl ester dimethanol
US5084581A (en) * 1990-12-18 1992-01-28 E. R. Squibb & Sons, Inc. Process for preparing (3R-(3aα,4β,7ββ,7aα))-octahydro-4,7 epoxyisobenzofuranol from associated aldehydes
CA2055572A1 (en) * 1990-12-18 1992-06-19 David Kronenthal Processes and intermediates for thromboxane receptor antagonists
US5266710A (en) * 1990-12-18 1993-11-30 Patel Ramesh N (Exo,exo)-7-oxabicyclo[2.2.1]heptane-2,3-dimethanol; monoacyl ester and diacyl ester
US5126370A (en) * 1990-12-24 1992-06-30 E. R. Squibb & Sons, Inc. Anti-thrombotic heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7057057B2 (en) * 2002-05-22 2006-06-06 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP3804717A1 (en) 2014-05-16 2021-04-14 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating systemic sclerosis or pulmonary arterial hypertension
MX2017017155A (es) 2015-06-30 2018-08-09 Cumberland Pharmaceuticals Inc Antagonistas del receptor de tromboxano en erea/asma.
CN115624549A (zh) 2016-05-11 2023-01-20 坎伯兰医药品股份有限公司 用血栓烷-a2受体拮抗剂治疗肌营养不良的组合物和方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0045118B1 (en) * 1979-01-05 1984-04-04 National Research Development Corporation Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2z-enes
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
AU561739B2 (en) * 1981-12-23 1987-05-14 British Technology Group Limited Prostaglandins
KR840003462A (ko) 1982-05-14 1984-09-08 데이빗 핸더슨 복합성분의 가소물질투여 및 혼합총
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4456615A (en) 1982-10-25 1984-06-26 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction
US4456617A (en) * 1983-01-12 1984-06-26 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction
US4533673A (en) * 1984-01-26 1985-08-06 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted enaminone prostaglandin analogs and their use in treatment of thrombolytic disease
US4536514A (en) * 1984-04-06 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombolytic disease
US4654356A (en) * 1985-08-01 1987-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diacid diamide prostaglandin analogs

Also Published As

Publication number Publication date
JPS6263589A (ja) 1987-03-20
ES557753A0 (es) 1988-03-16
KR870001229A (ko) 1987-03-12
KR910004721B1 (ko) 1991-07-10
ES8801899A1 (es) 1988-03-01
EP0207684B1 (en) 1994-11-23
CN1009645B (zh) 1990-09-19
US4663336A (en) 1987-05-05
AU603058B2 (en) 1990-11-08
JPH07103125B2 (ja) 1995-11-08
PT82875B (pt) 1988-04-21
CN86105664A (zh) 1987-02-18
ES557752A0 (es) 1988-03-16
ES557748A0 (es) 1988-03-01
PT82875A (en) 1986-07-01
ES8802020A1 (es) 1988-03-16
ES557750A0 (es) 1988-03-01
ATE114312T1 (de) 1994-12-15
IL79210A (en) 1991-03-10
ES8900229A1 (es) 1989-04-01
IE861749L (en) 1987-01-01
HUT45041A (en) 1988-05-30
IE65827B1 (en) 1995-11-15
PH22413A (en) 1988-08-26
DE3650144D1 (de) 1995-01-05
NO168038C (no) 1992-01-08
DK162528B (da) 1991-11-11
NO862635L (no) 1987-01-02
FI93218B (fi) 1994-11-30
ES556530A0 (es) 1988-02-16
GR861711B (en) 1986-11-03
NZ216544A (en) 1990-02-26
IL79210A0 (en) 1986-09-30
ES8802016A1 (es) 1988-03-16
ES8801626A1 (es) 1988-02-16
EP0207684A3 (en) 1987-04-29
FI862797A (fi) 1987-01-02
NO862635D0 (no) 1986-06-30
FI93218C (fi) 1995-03-10
ES557746A0 (es) 1988-03-16
DK310686A (da) 1987-01-02
ES557747A0 (es) 1988-03-16
FI862797A0 (fi) 1986-07-01
ES557749A0 (es) 1989-04-01
ES557754A0 (es) 1987-12-01
HU196779B (en) 1989-01-30
ES8801898A1 (es) 1988-03-01
AU5871586A (en) 1987-01-08
NO168038B (no) 1991-09-30
ES8802018A1 (es) 1988-03-16
DK310686D0 (da) 1986-06-30
ES8802019A1 (es) 1988-03-16
DE3650144T2 (de) 1995-04-06
CA1284643C (en) 1991-06-04
ES8800896A1 (es) 1987-12-01
ES557751A0 (es) 1988-03-16
EP0207684A2 (en) 1987-01-07
DK162528C (da) 1992-03-30

Similar Documents

Publication Publication Date Title
ES8800896A1 (es) Un procedimiento para preparar derivados de diamidas sustituidas con 7-oxabicicloheptano y sus analogos de prostaglandina
ZA944884B (en) Derivatives of valproic acid amides and 2-valproenoic acid amides method of making and use thereof as anticonvulsant agent
EP0330461A3 (en) Piperidine derivatives
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
IE801364L (en) Clavulanic acid derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201